Advancing Regenerative Therapies for
Vascular Disease
Diseases driven by impaired blood flow and the body’s inability to repair damaged vasculature represent some of the most significant unmet medical needs.
NovoVessel is developing mRNA-based therapies designed to stimulate vascular repair, restore tissue health and recover function.
OUR FOCUS
We are initially focused on severe vascular disorders where current treatments slow progression but rarely reverse underlying damage.
SEVERE ISCHEMIA
Affects millions of patients worldwide with limited treatment options.
HIGH UNMET NEED
Affects millions of patients worldwide with limited treatment options.
RESTORE BLOOD FLOW
Rebuild vascular networks to improve oxygen delivery and tissue vitality.
PLATFORM APPROACH
Our mRNA platform has the potential to transform outcomes across multiple vascular diseases.
OUR APPROACH
Our proprietary mRNA platform is designed to deliver a coordinated set of regenerative signals that promote the body’s natural ability to repair and rebuild blood vessels.
DELIVER
mRNA therapeutics engineered for optimal performance.
STIMULATE
Activation of regenerative processes and new vessel formation.
RESTORE
Improved blood flow and tissue oxygenation.
RECOVER
Restoration of tissue health and function.
OUR THERAPEUTIC PIPELINE
Our lead programs are currently in preclinical development.
ROBUST RESEARCH
Supported by extensive in vitro and in vivo studies.
PRECLINICAL PHASE
Advancing multiple mRNA therapeutics targeting vascular regeneration.
STRONG IP POSITION
Proprietary platform and therapeutic compositions.
BROAD IMPACT POTENTIAL
Platform designed to address a range of vascular diseases.
Building a Future Where Regeneration Becomes the New Standard of Care.
By combining cutting-edge mRNA engineering with a deep understanding of vascular biology, we are developing therapies that aim not only to treat disease but to restore what disease has taken away.
Let’s advance regenerative medicine together.